The Latest Trading Price of Beryl Drugs Ltd is ₹ 21.75 as of 05 May 15:30
. The P/E Ratio of Beryl Drugs Ltd changed from 14.1 on March 2021 to 18.5 on March 2025 . This represents a CAGR of 5.58% over 5 yearsThe P/E Ratio of Source Natural Foods & Herbal Supplements Ltd changed from 28.2 on March 2021 to 46.2 on March 2025 . This represents a CAGR of 10.38% over 5 years The Market Cap of Beryl Drugs Ltd changed from ₹ 3.35 crore on March 2021 to ₹ 10.68 crore on March 2025 . This represents a CAGR of 26.10% over 5 yearsThe Market Cap of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 95.27 crore on March 2021 to ₹ 133.98 crore on March 2025 . This represents a CAGR of 7.06% over 5 years The revenue of Beryl Drugs Ltd for the Dec '25 is ₹ 3.85 crore as compare to the Sep '25 revenue of ₹ 5.16 crore. This represent the decline of -25.39% The revenue of Source Natural Foods & Herbal Supplements Ltd for the Dec '25 is ₹ 20.3 crore as compare to the Sep '25 revenue of ₹ 16.95 crore. This represent the growth of 19.76% The ebitda of Beryl Drugs Ltd for the Dec '25 is ₹ -0.2 crore as compare to the Sep '25 ebitda of ₹ 0.73 crore. This represent the decline of -127% The ebitda of Source Natural Foods & Herbal Supplements Ltd for the Dec '25 is ₹ 1.53 crore as compare to the Sep '25 ebitda of ₹ 1.36 crore. This represent the growth of 12.5% The net profit of Beryl Drugs Ltd changed from ₹ 0.37 crore to ₹ -0.17 crore over 7 quarters. This represents a CAGR of NaN%
The net profit of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 0.42 crore to ₹ 0.82 crore over 7 quarters. This represents a CAGR of 46.57%
The Dividend Payout of Beryl Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Source Natural Foods & Herbal Supplements Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Beryl Drugs Ltd
Beryl Drugs Limited was incorporated on August 24, 1993.
The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993.
The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.
The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally.
It offers I.V. fluids, and a range of small and large volume injectables.
It provides a range of eye/ear drops, veterinary products, and injections.
About Source Natural Foods & Herbal Supplements Ltd
Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995.
The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12.
The Company engages in the pharmaceutical business in India.
It provides allopathic and ayurvedic formulations.
Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets.
Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country.
FAQs for the comparison of Beryl Drugs Ltd and Source Natural Foods & Herbal Supplements Ltd
Which company has a larger market capitalization, Beryl Drugs Ltd or Source Natural Foods & Herbal Supplements Ltd?
Market cap of Beryl Drugs Ltd is 11 Cr while Market cap of Source Natural Foods & Herbal Supplements Ltd is 83 Cr
What are the key factors driving the stock performance of Beryl Drugs Ltd and Source Natural Foods & Herbal Supplements Ltd?
The stock performance of Beryl Drugs Ltd and Source Natural Foods & Herbal Supplements Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Beryl Drugs Ltd and Source Natural Foods & Herbal Supplements Ltd?
As of May 5, 2026, the Beryl Drugs Ltd stock price is INR ₹21.75. On the other hand, Source Natural Foods & Herbal Supplements Ltd stock price is INR ₹129.95.
How do dividend payouts of Beryl Drugs Ltd and Source Natural Foods & Herbal Supplements Ltd compare?
To compare the dividend payouts of Beryl Drugs Ltd and Source Natural Foods & Herbal Supplements Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.